vs
El Pollo Loco Holdings, Inc.（LOCO）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是El Pollo Loco Holdings, Inc.的1.7倍（$207.3M vs $123.5M），El Pollo Loco Holdings, Inc.净利率更高（5.3% vs -62.0%，领先67.3%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 8.1%），El Pollo Loco Holdings, Inc.自由现金流更多（$5.1M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 3.1%）
El Pollo Loco Holdings, Inc.是总部设在美国加利福尼亚州科斯塔梅萨的连锁餐饮品牌，主打墨西哥风味烤鸡肉产品，目前在美国西南部地区经营着约500家自营与加盟门店，多数门店提供堂食和外带服务，部分门店还开设了得来购驾车取餐通道。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
LOCO vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $123.5M | $207.3M |
| 净利润 | $6.5M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 8.3% | -54.7% |
| 净利率 | 5.3% | -62.0% |
| 营收同比 | 8.1% | 25.9% |
| 净利润同比 | 9.9% | 3.5% |
| 每股收益（稀释后） | $0.22 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $123.5M | $207.3M | ||
| Q3 25 | $121.5M | $159.9M | ||
| Q2 25 | $125.8M | $166.5M | ||
| Q1 25 | $119.2M | $139.3M | ||
| Q4 24 | $114.3M | $164.6M | ||
| Q3 24 | $120.4M | $139.5M | ||
| Q2 24 | $122.2M | $147.0M | ||
| Q1 24 | $116.2M | $108.8M |
| Q4 25 | $6.5M | $-128.6M | ||
| Q3 25 | $7.4M | $-180.4M | ||
| Q2 25 | $7.1M | $-115.0M | ||
| Q1 25 | $5.5M | $-151.1M | ||
| Q4 24 | $6.0M | $-133.2M | ||
| Q3 24 | $6.2M | $-133.5M | ||
| Q2 24 | $7.6M | $-131.6M | ||
| Q1 24 | $5.9M | $-170.7M |
| Q4 25 | 8.3% | -54.7% | ||
| Q3 25 | 9.4% | -106.9% | ||
| Q2 25 | 9.0% | -64.8% | ||
| Q1 25 | 7.5% | -102.6% | ||
| Q4 24 | 7.9% | -74.3% | ||
| Q3 24 | 8.4% | -94.6% | ||
| Q2 24 | 10.1% | -79.1% | ||
| Q1 24 | 8.3% | -151.9% |
| Q4 25 | 5.3% | -62.0% | ||
| Q3 25 | 6.1% | -112.8% | ||
| Q2 25 | 5.6% | -69.0% | ||
| Q1 25 | 4.6% | -108.5% | ||
| Q4 24 | 5.2% | -80.9% | ||
| Q3 24 | 5.1% | -95.7% | ||
| Q2 24 | 6.2% | -89.5% | ||
| Q1 24 | 5.1% | -156.8% |
| Q4 25 | $0.22 | $-1.28 | ||
| Q3 25 | $0.25 | $-1.81 | ||
| Q2 25 | $0.24 | $-1.17 | ||
| Q1 25 | $0.19 | $-1.57 | ||
| Q4 24 | $0.21 | $-1.34 | ||
| Q3 24 | $0.21 | $-1.40 | ||
| Q2 24 | $0.25 | $-1.52 | ||
| Q1 24 | $0.19 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.2M | $421.0M |
| 总债务越低越好 | $51.0M | — |
| 股东权益账面价值 | $291.1M | $-80.0M |
| 总资产 | $606.6M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.18× | — |
8季度趋势，按日历期对齐
| Q4 25 | $6.2M | $421.0M | ||
| Q3 25 | $10.9M | $202.5M | ||
| Q2 25 | $9.0M | $176.3M | ||
| Q1 25 | $4.3M | $127.1M | ||
| Q4 24 | $2.5M | $174.0M | ||
| Q3 24 | $7.9M | $150.6M | ||
| Q2 24 | $10.5M | $480.7M | ||
| Q1 24 | $9.1M | $112.3M |
| Q4 25 | $51.0M | — | ||
| Q3 25 | $61.0M | — | ||
| Q2 25 | $69.0M | — | ||
| Q1 25 | $73.0M | — | ||
| Q4 24 | $71.0M | — | ||
| Q3 24 | $76.0M | — | ||
| Q2 24 | $87.0M | — | ||
| Q1 24 | $80.0M | — |
| Q4 25 | $291.1M | $-80.0M | ||
| Q3 25 | $282.9M | $9.2M | ||
| Q2 25 | $274.2M | $151.3M | ||
| Q1 25 | $265.7M | $144.2M | ||
| Q4 24 | $260.7M | $255.0M | ||
| Q3 24 | $255.2M | $346.8M | ||
| Q2 24 | $248.6M | $432.4M | ||
| Q1 24 | $256.3M | $140.3M |
| Q4 25 | $606.6M | $1.5B | ||
| Q3 25 | $602.7M | $1.2B | ||
| Q2 25 | $596.8M | $1.3B | ||
| Q1 25 | $590.5M | $1.3B | ||
| Q4 24 | $592.0M | $1.5B | ||
| Q3 24 | $590.0M | $1.5B | ||
| Q2 24 | $593.8M | $1.6B | ||
| Q1 24 | $598.0M | $1.3B |
| Q4 25 | 0.18× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.25× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | 0.27× | — | ||
| Q3 24 | 0.30× | — | ||
| Q2 24 | 0.35× | — | ||
| Q1 24 | 0.31× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.9M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $5.1M | $-100.8M |
| 自由现金流率自由现金流/营收 | 4.1% | -48.6% |
| 资本支出强度资本支出/营收 | 7.1% | 0.5% |
| 现金转化率经营现金流/净利润 | 2.13× | — |
| 过去12个月自由现金流最近4个季度 | $25.4M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $13.9M | $-99.8M | ||
| Q3 25 | $15.3M | $-91.4M | ||
| Q2 25 | $14.1M | $-108.3M | ||
| Q1 25 | $4.7M | $-166.5M | ||
| Q4 24 | $5.6M | $-79.3M | ||
| Q3 24 | $13.0M | $-67.0M | ||
| Q2 24 | $17.0M | $-77.0M | ||
| Q1 24 | $11.2M | $-190.7M |
| Q4 25 | $5.1M | $-100.8M | ||
| Q3 25 | $9.9M | $-92.7M | ||
| Q2 25 | $9.1M | $-110.7M | ||
| Q1 25 | $1.3M | $-167.8M | ||
| Q4 24 | $1.1M | $-79.5M | ||
| Q3 24 | $9.1M | $-68.6M | ||
| Q2 24 | $10.4M | $-79.0M | ||
| Q1 24 | $7.0M | $-193.9M |
| Q4 25 | 4.1% | -48.6% | ||
| Q3 25 | 8.2% | -58.0% | ||
| Q2 25 | 7.2% | -66.5% | ||
| Q1 25 | 1.1% | -120.5% | ||
| Q4 24 | 1.0% | -48.3% | ||
| Q3 24 | 7.6% | -49.2% | ||
| Q2 24 | 8.5% | -53.7% | ||
| Q1 24 | 6.0% | -178.2% |
| Q4 25 | 7.1% | 0.5% | ||
| Q3 25 | 4.4% | 0.8% | ||
| Q2 25 | 4.0% | 1.5% | ||
| Q1 25 | 2.8% | 1.0% | ||
| Q4 24 | 3.9% | 0.1% | ||
| Q3 24 | 3.2% | 1.2% | ||
| Q2 24 | 5.3% | 1.4% | ||
| Q1 24 | 3.6% | 3.0% |
| Q4 25 | 2.13× | — | ||
| Q3 25 | 2.08× | — | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 0.95× | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 2.22× | — | ||
| Q1 24 | 1.89× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LOCO
| Services | $102.4M | 83% |
| Franchise | $13.0M | 11% |
| Franchise Advertising Fee | $8.1M | 7% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
